Status:
UNKNOWN
Study for Detection of Donor-derived Cell-free DNA After Renal Transplantation Using Devysers NGS-based Chimerism Assay.
Lead Sponsor:
Sheba Medical Center
Collaborating Sponsors:
Dan Hauzenberger M.D., Ph.D. Assoc. Professor, Karolinska University Hospital Sweden
Conditions:
Cell-Free Nucleic Acids
Eligibility:
All Genders
20-70 years
Brief Summary
The aim of this study is to evaluate highly sensitive quantitative tests for early molecular detection of graft rejection and associated immune response from liquid biopsies in the blood from patients...
Detailed Description
Each year 40-60 patients undergo renal transplant with a living donor (LD) at Karolinska University Hospital. Prior to transplantation, these patients and their donors are investigated for their immun...
Eligibility Criteria
Inclusion
- Patients older than 20 undergoing kidney transplantation -
Exclusion
- Patients included in other studies Patients a combined transplant with other donor Patients not eligible to sign an inform consent Patients with primary non-function or those that lost their graft during the first 3 months
- \-
Key Trial Info
Start Date :
April 1 2022
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
March 31 2024
Estimated Enrollment :
50 Patients enrolled
Trial Details
Trial ID
NCT05226936
Start Date
April 1 2022
End Date
March 31 2024
Last Update
February 7 2022
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.